Novel antigens for enterotoxigenic Escherichia coli vaccines

Expert Review of Vaccines

Volumn 13, Issue 5, 2014, Pages 631-639

  Fleckenstein, James ^a,b   Sheikh, Alaullah ^a   Qadri, Firdausi ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

bacterial; bacterial adhesions; enterotoxigenic; enterotoxigenic Escherichia coli; enterotoxins; Escherichia coli; fimbriae; flagella; vaccines

Indexed keywords

ANTIGEN; ENTEROTOXIGENIC ESCHERICHIA COLI VACCINE; ESCHERICHIA COLI VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN;

BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; ENTEROTOXIGENIC ESCHERICHIA COLI; FIMBRIA; IMMUNITY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; HUMAN; IMMUNOLOGY;

ANIMALS; ANTIGENS, BACTERIAL; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; HUMANS;

EID: 84921282085     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.905745     Document Type: Review

References (95)

1. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005; 18(3):465-83
2. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet 2013;382(9888): 209-22
3. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: Systematic review from 1973 to the present. Am J Trop Med Hyg 2009;80(4):609-14
4. Schlor S, Riedl S, Blass J, Reidl J. Genetic rearrangements of the regions adjacent to genes encoding heat-labile enterotoxins (eltAB) of enterotoxigenic Escherichia coli strains. Appl Environ Microbiol 2000;66(1): 352-8
5. Fleckenstein JM, Hardwidge PR, Munson GP, et al. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect 2010;12(2):89-98
6. Gill DM, Richardson SH. Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: Comparison with cholera toxin. J Infect Dis 1980;141(1):64-70
7. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981;292(5822):413-17
8. Rao MC. Toxins which activate guanylate cyclase: Heat-stable enterotoxins. Ciba Found Symp 1985;112:74-93
9. Chao AC, de Sauvage FJ, Dong YJ, et al. Activation of intestinal CFTR Cl-channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J 1994;13(5):1065-72
10. Pitari GM, Zingman LV, Hodgson DM, et al. Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA 2003;100(5):2695-9
11. Sack DA, Merson MH, Wells JG, et al. Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet 1975;2(7928):239-41
12. Bolin I, Wiklund G, Qadri F, et al. Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelers. J Clin Microbiol 2006;44(11):3872-7
13. Qadri F, Das SK, Faruque ASG, et al. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol 2000;38(1):27-31
14. Sack RB. The discovery of cholera-like enterotoxins produced by Escherichia coli causing secretory diarrhoea in humans. Indian J Med Res 2011;133(2):171-80
15. Sack RB, Gorbach SL, Banwell JG, et al. Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis 1971;123(4):378-85
16. Vicente AC, Teixeira LF, Iniguez-Rojas L, et al. Outbreaks of cholera-like diarrhoea caused by enterotoxigenic Escherichia coli in the Brazilian Amazon Rainforest. Trans R Soc Trop Med Hyg 2005;99(9):669-74
17. Finkelstein RA, Vasil ML, Jones JR, et al. Clinical cholera caused by enterotoxigenic Escherichia coli. J Clin Microbiol 1976; 3(3):382-4
18. Peruski LF Jr, Kay BA, El-Yazeed RA, et al. Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in Periurban Egypt. J Clin Microbiol 1999; 37(9):2974-8
19. Qadri F, Saha A, Ahmed T, et al. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 2007;75(8):3961-8
20. Ahmed T, Bhuiyan TR, Zaman K, et al. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev 2013;7: CD009029
21. Fleckenstein JM, Munson GM, Rasko D. Enterotoxigenic Escherichia coli: Orchestrated host engagement. Gut Microbes 2013;4(5). [Epub ahead to print]
22. Roy K, Bartels S, Qadri F, Fleckenstein JM. Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect Immun 2010;78(7):3027-35
23. Rasko DA, Rosovitz MJ, Myers GS, et al. The pangenome structure of Escherichia coli: Comparative genomic analysis of Escherichia coli commensal and pathogenic isolates. J Bacteriol 2008;190(20):6881-93
24. Wolf MK. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev 1997;10(4):569-84
25. Crossman LC, Chaudhuri RR, Beatson SA, et al. A commensal gone bad: Complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol 2010;192(21):5822-31
26. Steinsland H, Valentiner-Branth P, Gjessing HK, et al. Protection from natural infections with enterotoxigenic Escherichia coli: Longitudinal study. Lancet 2003; 362(9380):286-91
27. Clemens JD, Svennerholm AM, Harris JR, et al. Seroepidemiologic evaluation of anti-Toxic and anti-colonization factor immunity against infections by LT-producing Escherichia coli in rural Bangladesh. J Infect Dis 1990;162(2): 448-53
28. Rao MR, Wierzba TF, Savarino SJ, et al. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea. J Infect Dis 2005;191(4):562-70
29. Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013;56(10):1458-65
30. Isidean SD, Riddle MS, Savarino SJ, Porter CK. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 2011; 29(37):6167-78
31. Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol 1996;4(11): 444-52
32. Savarino SJ, Brown FM, Hall E, et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J Infect Dis 1998;177(3): 796-9
33. Tobias J, Svennerholm AM. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates. Appl Microbiol Biotechnol 2012;93(6):2291-300
34. Qadri F, Ahmed T, Ahmed F, et al. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age. Vaccine 2003;21(19-20):2394-403
35. Sack DA, Shimko J, Torres O, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic Escherichia coli diarrhoea of travellers to Guatemala and Mexico. Vaccine 2007;25(22):4392-400
36. Lundgren A, Leach S, Tobias J, et al. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine 2013;31(8): 1163-70
37. Turner AK, Terry TD, Sack DA, et al. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun 2001;69(8):4969-79
38. Turner AK, Stephens JC, Beavis JC, et al. Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B. Clin Vaccine Immunol 2011; 18(12):2128-35
39. Harro C, Sack D, Bourgeois AL, et al. A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and LTB is well tolerated and immunogenic in a placebo-controlled double-blind Phase I trial in healthy adults. Clin Vaccine Immunol 2011;18(12):2118-27
40. Darsley MJ, Chakraborty S, Denearing B, et al. ACE527 Oral, live attenuated ETEC vaccine reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol 2012;19(12):1921-31
41. Mu XQ, Savarino SJ, Bullitt E. The three-dimensional structure of CFA/I adhesion pili: Traveler's diarrhea bacteria hang on by a spring. J Mol Biol 2008; 376(3):614-20
42. Li YF, Poole S, Nishio K, et al. Structure of CFA/I fimbriae from enterotoxigenic Escherichia coli. Proc Natl Acad Sci USA 2009;106(96):10793-8
43. Chaux P, Guy B, Gregory M, et al. Towards a protein-based vaccine against ETEC and Shigella. Vaccines for enteric diseases. Bangkok, Thailand; 2013
44. Barry EM, Altboum Z, Losonsky G, Levine MM. Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vaccine 2003;21(5-6):333-40
45. Barry EM, Wang J, Wu T, et al. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model. Vaccine 2006;24(18): 3727-34
46. Koprowski H II, Levine MM, Anderson RJ, et al. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli. Infect Immun 2000;68(9):4884-92
47. Levine MM, Kotloff KL, Barry EM, et al. Clinical trials of Shigella vaccines: Two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007;5(7):540-53
48. Ranallo RT, Fonseka CP, Cassels F, et al. Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli. Infect Immun 2005;73(1): 258-67
49. Giron JA, Xu JG, Gonzalez CR, et al. Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908. Vaccine 1995;13(10): 939-46
50. Khan SA, Stratford R, Wu T, et al. Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors. Vaccine 2003;21(5-6):538-48
51. Yamamoto T, Tamura Y, Yokota T. Enteroadhesion fimbriae and enterotoxin of Escherichia coli: Genetic transfer to a streptomycin-resistant mutant of the galE oral-route live-vaccine Salmonella typhi Ty21a. Infect Immun 1985;50(3):925-8
52. Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. Int J Med Microbiol 2013;303(3):105-13
53. Xu D, Cisar JO, Poly F, et al. Genome sequence of salmonella enterica serovar typhi oral vaccine strain Ty21a. Genome Announcement 2013;1(4):e00650-13
54. Mason HS, Haq TA, Clements JD, Arntzen CJ. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene. Vaccine 1998;16(13): 1336-43
55. Walmsley AM, Arntzen CJ. Plants for delivery of edible vaccines. Curr Opin Biotechnol 2000;11(2):126-9
56. Tacket CO, Mason HS, Losonsky G, et al. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 1998;4(5): 607-9
57. Tacket CO, Pasetti MF, Edelman R, et al. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 2004;22(31-32):4385- 9
58. Behrens RH, Cramer JP, Jelinek T, et al. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: A phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis 2013;14(3):197-204
59. Fleckenstein JM, Roy K, Fischer JF, Burkitt M. Identification of a two-partner secretion locus of enterotoxigenic Escherichia coli. Infect Immun 2006;74(4): 2245-58
60. Patel SK, Dotson J, Allen KP, Fleckenstein JM. Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli. Infect Immun 2004;72(3): 1786-94
61. Roy K, Hamilton D, Allen KP, et al. The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection. Infect Immun 2008;76(5):2106-12
62. Roy K, Hamilton DJ, Fleckenstein JM. Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli. Clin Vaccine Immunol 2012;19(10): 1603-8
63. Roy K, Hilliard GM, Hamilton DJ, et al. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature 2009;457(7229): 594-8
64. Roy K, Hamilton D, Ostmann MM, Fleckenstein JM. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model. Vaccine 2009;27(34):4601-8
65. Sahl JW, Steinsland H, Redman JC, et al. A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation. Infect Immun 2011;79(2):950-60
66. Del Canto F, Valenzuela P, Cantero L, et al. Distribution of classical and nonclassical virulence genes in enterotoxigenic Escherichia coli isolates from chilean children and tRNA gene screening for putative insertion sites for genomic islands. J Clin Microbiol 2011;49(9): 3198-203
67. Roy K, Kansal R, Bartels SR, et al. Adhesin degradation accelerates delivery of heat-labile toxin by enterotoxigenic Escherichia coli. J Biol Chem 2011;286(34):29771-9
68. Kumar P, Luo Q, Vickers TJ, et al. EatA, an immununogenic protective antigen of enterotoxigenic Escherichia coli degrades intestinal mucin. Infect Immun 2013;82(2): 500-8
69. Gonzales L, Sanchez S, Zambrana S, et al. Molecular characterization of enterotoxigenic Escherichia coli isolates recovered from children with diarrhea during a 4-year period (2007 to 2010) in Bolivia. J Clin Microbiol 2013;51(4): 1219-25
70. Benjelloun-Touimi Z, Sansonetti PJ, Parsot C. SepA, the major extracellular protein of Shigella flexneri: Autonomous secretion and involvement in tissue invasion. Mol Microbiol 1995;17(1):123-35
71. Boisen N, Scheutz F, Rasko DA, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis 2012;205(3): 431-44
72. Strozen TG, Li G, Howard SP. YghG (GspSbeta) is a novel pilot protein required for localization of the GspSbeta type II secretion system secretin of enterotoxigenic Escherichia coli. Infect Immun 2012;80(8): 2608-22
73. Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci USA 2010; 107(20):9072-7
74. Luo Q, Kumar P, Vickers T, et al. Enterotoxigenic Escherichia coli secrete a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells. Infect Immun 2013;82(2):509-21
75. Chen Q, Savarino SJ, Venkatesan MM. Subtractive hybridization and optical mapping of the enterotoxigenic Escherichia coli H10407 chromosome: Isolation of unique sequences and demonstration of significant similarity to the chromosome of Escherichia coli K-12. Microbiology 2004; 152(Pt 4):1041-54
76. Kansal R, Rasko DA, Sahl JW, et al. Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions. Infect Immun 2013;81(1): 259-70
77. Staunton DE, Marlin SD, Stratowa C, et al. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52(6):925-33
78. Nesta B, Spraggon G, Alteri C, et al. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. mBio 2012;3(2):1-9
79. Levine MM. Adhesion of enterotoxigenic Escherichia coli in humans and animals. Ciba Found Symp 1981;80:142-60
80. Knutton S, Lloyd DR, Candy DC, McNeish AS. Adhesion of enterotoxigenic Escherichia coli to human small intestinal enterocytes. Infect Immun 1985;48(3): 824-31
81. Jayappa HG, Goodnow RA, Geary SJ. Role of Escherichia coli type 1 pilus in colonization of porcine ileum and its protective nature as a vaccine antigen in controlling colibacillosis. Infect Immun 1985;48(2):350-4
82. Levine MM, Ristaino P, Sack RB, et al. Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: Relation to enterotoxin type. Infect Immun 1983;39(2):889-97
83. Levine MM, Black RE, Brinton CC Jr, et al. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand J Infect Dis Suppl 1982;33: 83-95
84. Waksman G, Hultgren SJ. Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol 2009; 7(11):765-74
85. Langermann S, Mollby R, Burlein JE, et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000;181(2):774-8
86. Pouttu R, Westerlund-Wikstrom B, Lang H, et al. matB, a common fimbrillin gene of Escherichia coli, expressed in a genetically conserved, virulent clonal group. J Bacteriol 2001;183(16):4727-36
87. Rendon MA, Saldana Z, Erdem AL, et al. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci USA 2007;104(25):10637-42
88. Blackburn D, Husband A, Saldana Z, et al. Distribution of the Escherichia coli common pilus among diverse strains of human enterotoxigenic Escherichia coli. J Clin Microbiol 2009;47(6):1781-4
89. Garnett JA, Martinez-Santos VI, Saldana Z, et al. Structural insights into the biogenesis and biofilm formation by the Escherichia coli common pilus. Proc Natl Acad Sci USA 2012;109(10):3950-5
90. Harris JA, Roy K, Woo-Rasberry V, et al. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis 2011;5(12):e1428
91. Norton EB, Lawson LB, Freytag LC, Clements JD. Characterization of a mutant Escherichia coli heat-labile toxin, LT (R192G/L211A), as a safe and effective oral adjuvant. Clin Vaccine Immunol 2011; 18(4):546-51
92. El-Kamary SS, Cohen MB, Bourgeois AL, et al. Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli. Clin Vaccine Immunol 2013;20(11):1764-70
93. Puntervoll P, Clements JD, Diaz Y, et al. Rational design of a vaccine against the heat-stable toxin of enterotoxigenic Escherichia coli. Vaccines for enteric diseases. Bangkok, Thailand; 2013
94. Liu M, Ruan X, Zhang C, et al. Heat-labile (LT) and heat-stable (STa) toxoid fusions (LTR192G-STaP13F) of human enterotoxigenic Escherichia coli elicited 'neutralizing antitoxin antibodies. Infect Immun 2011;79(10):4002-9
95. Ruan X, Clements JD, Robertson DC, et al. Heat-stable (STa) toxoids of enterotoxigenic Escherichia coli for toxoid fusions with double mutant heat-labile toxin (dmLT) elicit neutralizing anti-STa antibodies. Vaccines for enteric diseases. Bangkok, Thailand; 2013